The effect of vitamin B1 (thiamine) on blood pressure, lipid profile, liver enzymes and fasting blood sugar in the military with metabolic syndrome

The effect of vitamin B1 (thiamine) on blood pressure, lipid profile, liver enzymes and fasting blood sugar in patients with metabolic syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180201038585N5

Enrollment

116

Registered

2019-11-10

Start date

2019-10-17

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome. Endocrine, nutritional and metabolic diseases

Interventions

Intervention 1: Intervention group: Vitamin B1, 100 mg, every day, darou pakhsh. Intervention 2: Control group: Placebo.

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: age: 25 -50 years Military personnel with metabolic syndrome

Exclusion criteria

Exclusion criteria: Having a history of cardiovascular disease morbility liver, kidney Consumption alcoho, smoking ,supplementation and certain drugs People who during the study less than 80% of the tablets vitamin b1 and placebo to consume.

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Triglyceride. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Cholesterol. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Blood presure. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Alanin transfrase. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.	—

Measure

Time frame

Fasting blood sugar. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Triglyceride. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Cholesterol. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Blood presure. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.;Alanin transfrase. Timepoint: before intervention and end of intervention. Method of measurement: Lab kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkarim Parastouei

Bagheiat-allah University of Medical Sciences

karimparastouei@gmail.com+98 21 8248 3264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026